Zantac maker halts heartburn drug’s distribution after cancer concerns Posted by: Stonecom Interactive Wednesday, September 18, 2019 Novartis said it’s conducting its own investigation into traces of a potentially cancer-causing ingredient in Zantac Source 2019-09-18 Stonecom Interactive